ConductScience.org, home

Trial · NCT03358134

Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis

NCT03358134, Phase 3, Completed, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis. Trials, record NCT03358134. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03358134

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis
NCT number
NCT03358134
Status
Completed
Phases
Phase 3
Enrollment
20 participants, actual
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions
Spondylarthropathies
Interventions
Secukinumab
First posted
2017-11-30
Last updated
2017-11-30
Other registries' IDs
eudract:2013-002709-79

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBiological changes induced by therapy on target tissue (synovium)week 0 and week 12
Molecular changes of the synovium as measured by expression of several cytokines/chemokines by quantitative polymerase chain reaction (qPCR) as measured by a change in cytokine expression between baseline and week 12.
PrimaryChanges of cellular infiltrate in the target tissue (synovium)week 0 and week 12Changes in cell count measured by immunohistochemistry (on a 0-4 semi-quantitative analysis scale)
SecondaryAdverse eventsbetween day0 and 2 yrs of treatmentNumber of patients with adverse events as a measure of safety and tolerability
SecondaryVessel wall inflammationweek 0 and week 12Changes in Fludeoxyglucose (FDG18) PET/CT uptake in the vessel walls of the carotic arteries and aorta as measured by CT values

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03358134

GET https://conductscience.org/api/trials/v1/NCT03358134/registered